Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
human clinical data is limited
GLP-1 Nutritional Support Market Analysis - Size, Share, and Forecast Outlook 2025 to 2035 Industry Size (2025): USD 4.1 Bn Forecast (2035): USD 13 Bn CAGR (2025 to 2035): 12.2% GLP-1 Nutritional Support Market Size, Share, and Forecast Outlook 2025 to 2035 The GLP-1 nutritional support market is forecast to reach USD 13 billion by 2035, up from USD 4.1 billion in 2025, advancing at a 12.2% CAGR
Metabolic health beyond weight loss Examining effects on insulin sensitivity, lipid metabolism, and cardiovascular risk markers independent of weight changes
In this context, "claims evaluated" refers to an effort to clarify how the product is described across its marketing materials and how those descriptions align with ingredient-level research and general scientific understanding
On one hand, these therapies are helping to destigmatize obesity by emphasizing its biological underpinnings and offering an effective, evidence-based medical intervention.[172] On the other hand, their growing use for cosmetic or lifestyle purposes, particularly among public figures and celebrities, risks reframing obesity drugs as luxury wellness products rather than critical clinical tools for managing chronic disease.[173] This blurring of clinical necessity and aesthetic demand may undermine public understanding of the serious health risks associated with obesity and detract from the therapeutic value GLP-1s offer to medically at-risk populations.[174] It is therefore critical that public and policy discourse clearly center these medications within the context of metabolic and chronic disease management
, .
